{"id":3667,"date":"2023-10-12T10:17:52","date_gmt":"2023-10-12T02:17:52","guid":{"rendered":"http:\/\/www.sinotau.com\/chronicle\/2019\/"},"modified":"2025-05-28T13:47:11","modified_gmt":"2025-05-28T05:47:11","slug":"2023%e5%b9%b4","status":"publish","type":"chronicle","link":"https:\/\/www.sinotau.com\/en\/chronicle\/2023%e5%b9%b4\/","title":{"rendered":"2023\u5e74"},"content":{"rendered":"\n<ul class=\"wp-block-list\">\n<li>We completed Jun-2023 Capital Increase and raised approximately RMB1,100 million.<\/li>\n\n\n\n<li>We received regulatory approval from NMPA for XTR005 (\u6b27\u97e6\u5b81\u00ae)<\/li>\n\n\n\n<li>Glotope commenced radiopharmaceutical CRO\/CDMO business<\/li>\n\n\n\n<li>We obtained clinical trial approval for XTR006<\/li>\n<\/ul>\n\n\n\n\n","protected":false},"featured_media":0,"template":"","class_list":["post-3667","chronicle","type-chronicle","status-publish","hentry"],"meta_box":[],"_links":{"self":[{"href":"https:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/chronicle\/3667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/chronicle"}],"about":[{"href":"https:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/types\/chronicle"}],"wp:attachment":[{"href":"https:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/media?parent=3667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}